Skip to main content

Table 1 Baseline characteristics of patients with mutated DNA in plasma (N = 77)

From: Monitoring the effect of first line treatment in RAS/RAF mutated metastatic colorectal cancer by serial analysis of tumor specific DNA in plasma

  All patients with mutated DNA in plasma
Parameter N (%)
Age, years
 Median (range) 66 (35–79)
Gender
 Female 29 (38)
 Male 48 (62)
PS
 0–1 73 (95)
 2 4 (5)
Location of primary tumor
 Right/transverse colon 25 (32)
 Left colon 21 (27)
 Rectum 31 (40)
Primary disseminated disease 63 (81)
Number of metastatic sites
  ≤ 2 53 (69)
  > 2 24 (31)
Mutations in plasma DNA
 KRAS 64 (83)
 NRAS 3 (4)
 BRAF 10 (13)
  1. Abbreviations: N, number; PS, performance status. Some percentages do not add up to 100% due to rounding